RETRACTED: Loss of Heterozygosity and DNA Methylation Affect Germline Fibroblast Growth Factor Receptor 4 Polymorphism to Direct Allelic Selection in Breast Cancer
Xuegong Zhu(University Health Network), Shereen Ezzat(Ontario Institute for Cancer Research)
Cited by 10
Related Papers
The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis
|Cancer Research|2008|137
Epigenetic Silencing through DNA and Histone Methylation of Fibroblast Growth Factor Receptor 2 in Neoplastic Pituitary Cells
|American Journal Of Pathology|2007|94
Vitamin D Arrests Thyroid Carcinoma Cell Growth and Induces p27 Dephosphorylation and Accumulation through PTEN/Akt-Dependent and -Independent Pathways
|American Journal Of Pathology|2002|87
Targeting N-Cadherin through Fibroblast Growth Factor Receptor-4: Distinct Pathogenetic and Therapeutic Implications
|Molecular Endocrinology|2006|53
RETRACTED: Genetic and Epigenetic Mechanisms Down-Regulate FGF Receptor 2 to Induce Melanoma-Associated Antigen A in Breast Cancer
|American Journal Of Pathology|2010|17